These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1066 related items for PubMed ID: 19144487
41. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Kubaska S, Sahani DV, Saini S, Hahn PF, Halpern E. Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141 [Abstract] [Full Text] [Related]
42. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions. Winter TC, Freeny PC, Nghiem HV, Mack LA, Patten RM, Thomas CR, Elliott S. AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724 [Abstract] [Full Text] [Related]
43. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430 [Abstract] [Full Text] [Related]
44. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. Grandin C, Van Beers BE, Robert A, Gigot JF, Geubel A, Pringot J. J Comput Assist Tomogr; 1995 Feb; 19(3):412-8. PubMed ID: 7790551 [Abstract] [Full Text] [Related]
45. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Yamamoto H, Yamashita Y, Yoshimatsu S, Baba Y, Hatanaka Y, Murakami R, Nishiharu T, Takahashi M, Higashida Y, Moribe N. Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448 [Abstract] [Full Text] [Related]
46. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats]. Liu X, Xu YK, Huang QL, Wu YK. Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574 [Abstract] [Full Text] [Related]
47. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Lim JH, Choi D, Cho SK, Kim SH, Lee WJ, Lim HK, Park CK, Paik SW, Kim YI. Radiology; 2001 Sep; 220(3):669-76. PubMed ID: 11526265 [Abstract] [Full Text] [Related]
48. Focal liver lesion detection and characterization: comparison of non-contrast enhanced and SPIO-enhanced diffusion-weighted single-shot spin echo echo planar and turbo spin echo T2-weighted imaging. Coenegrachts K, Matos C, ter Beek L, Metens T, Haspeslagh M, Bipat S, Stoker J, Rigauts H. Eur J Radiol; 2009 Dec; 72(3):432-9. PubMed ID: 18849130 [Abstract] [Full Text] [Related]
49. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging. Halavaara JT, Lamminen AE, Bondestam S, Standertskjöld-Nordenstam CG, Hamberg LM. J Comput Assist Tomogr; 1994 Dec; 18(6):897-904. PubMed ID: 7962796 [Abstract] [Full Text] [Related]
50. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI]. Heim P, Steiner P, Schoder V, Dieckmann C, Kuhlencordt R, Adam G. Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107 [Abstract] [Full Text] [Related]
51. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging. Takahama K, Amano Y, Hayashi H, Ishihara M, Kumazaki T. Abdom Imaging; 2003 Oct; 28(4):525-30. PubMed ID: 14580096 [Abstract] [Full Text] [Related]
52. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). Saini S, Edelman RR, Sharma P, Li W, Mayo-Smith W, Slater GJ, Eisenberg PJ, Hahn PF. AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222 [Abstract] [Full Text] [Related]
53. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT. Lee JM, Kim IH, Kwak HS, Youk JH, Han YM, Kim CS. Korean J Radiol; 2003 May; 4(1):1-8. PubMed ID: 12679628 [Abstract] [Full Text] [Related]
54. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Tanimoto A, Kuribayashi S. Eur J Radiol; 2006 May; 58(2):200-16. PubMed ID: 16414230 [Abstract] [Full Text] [Related]
55. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence. Abe Y, Yamashita Y, Namimoto T, Tang Y, Takahashi M. Radiat Med; 2000 May; 18(2):97-105. PubMed ID: 10888042 [Abstract] [Full Text] [Related]
56. Improved detection of hepatic metastases from pancreatic cancer using periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) technique after SPIO administration. Hirokawa Y, Isoda H, Okada T, Arizono S, Shimada K, Yamamoto A, Shibata T, Togashi K. Invest Radiol; 2010 Mar; 45(3):158-64. PubMed ID: 20142748 [Abstract] [Full Text] [Related]
57. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227. Harisinghani MG, Saini S, Weissleder R, Halpern EF, Schima W, Rubin DL, Stillman AE, Sica GT, Small WC, Hahn PF. Radiology; 1997 Mar; 202(3):687-91. PubMed ID: 9051017 [Abstract] [Full Text] [Related]
58. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium]. Finazzo M, Midiri M, Gallo C, Bartolotta TV, Luca A. Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542 [Abstract] [Full Text] [Related]
59. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells. Tanimoto A, Wakabayashi G, Shinmoto H, Okuda S, Kuribayashi S, Mukai M. J Magn Reson Imaging; 2005 Mar; 21(3):230-6. PubMed ID: 15723373 [Abstract] [Full Text] [Related]
60. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Onishi H, Murakami T, Kim T, Hori M, Iannaccone R, Kuwabara M, Abe H, Nakata S, Osuga K, Tomoda K, Passariello R, Nakamura H. Radiology; 2006 Apr; 239(1):131-8. PubMed ID: 16484347 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]